|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Preeclampsia Risk Assessment (sFlt-1/PlGF Ratio)
Test Code15370
CPT Codes
83520 (x2)<br>Limited Access Code
Preferred Specimen
2 mL serum
Minimum Volume
0.5 mL
Other Acceptable Specimens
Plasma collected in a K2 EDTA (pink-top) tube
Instructions
Allow serum to clot completely at room temperature. Transfer 2 mL serum or plasma (Min: 0.5 mL) to a standard transport tube.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs) or Frozen
Specimen Stability
Room temperature: 24 hours
Refrigerated: 1 month
Frozen: 1 month
Refrigerated: 1 month
Frozen: 1 month
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Grossly hemolyzed, lipemic, and/or icteric specimens
Methodology
Quantitative Immunoassay
Setup Schedule
Set up: Daily; Report available: 2-4 days
Reference Range
≤ 39 ratio
Clinical Significance
This test is to be used in conjunction with other laboratory tests and clinical assessments to aid in the risk assessment of pregnant women (singleton pregnancies between gestational age 23+0 to 34+6/7 weeks) hospitalized for hypertensive disorders of pregnancy (preeclampsia, chronic hypertension with or without superimposed preeclampsia, or gestational hypertension) for progression to preeclampsia with severe features (as defined by American College of Obstetricians and Gynecologists guidelines) within 2 weeks of being tested.